论文信息 - Improved survival in multiple myeloma during the 2005–2009 and 2010–2014 periods - 字舞流文

Improved survival in multiple myeloma during the 2005–2009 and 2010–2014 periods

M. Mohty | P. Moreau | H. Avet-Loiseau | M. Macro | X. Leleu | J. Corre | T. Facon | V. Richez | L. Karlin | A. Perrot | A. Stoppa | M. Tiab | F. Orsini-Piocelle | S. Bréchignac | K. Belhadj | C. Hulin | D. Caillot | J. Marolleau | P. Collet | L. Voillat | F. Lifermann | M. Dib | J. Fontan | C. Mariette | H. Demarquette | L. Clément-Filliatre | C. Sohn | P. Rey | Borane Slama

[1] Andre H Crepaldi,et al. Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial , 2019, The Lancet.

[2] P. Sonneveld,et al. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study , 2019, The Lancet.

[3] H. Goldschmidt,et al. Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma. , 2019, The New England journal of medicine.

[4] T. Willis,et al. Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma. , 2018, Blood.

[5] Jesús Martín Sánchez,et al. Multiple Myeloma Treatment in Real‐world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study , 2018, Clinical lymphoma, myeloma & leukemia.

[6] H. Goldschmidt,et al. Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network , 2017, Leukemia.

[7] N. Munshi,et al. Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma , 2017, The New England journal of medicine.

[8] Christian Jacques,et al. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma. , 2014, The New England journal of medicine.

[9] H. Goldschmidt,et al. IMWG consensus on risk stratification in multiple myeloma , 2014, Leukemia.

[10] A. Palumbo,et al. Multiple myeloma. , 2011, The New England journal of medicine.

[11] O. Cope,et al. Multiple myeloma. , 1948, The New England journal of medicine.